A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD)

Rafat Alam, G. M. Sayedur Rahman, Nahid Hasan, Abu Sayeed Chowdhury. A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD). I. J. Computational Biology and Drug Design, 13(1):21-35, 2020. [doi]

@article{AlamRHC20,
  title = {A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD)},
  author = {Rafat Alam and G. M. Sayedur Rahman and Nahid Hasan and Abu Sayeed Chowdhury},
  year = {2020},
  doi = {10.1504/IJCBDD.2020.105103},
  url = {https://doi.org/10.1504/IJCBDD.2020.105103},
  researchr = {https://researchr.org/publication/AlamRHC20},
  cites = {0},
  citedby = {0},
  journal = {I. J.  Computational Biology and Drug Design},
  volume = {13},
  number = {1},
  pages = {21-35},
}